Investigator sites and their teams are hurting. COVID-19 is disrupting site operations and threatening global capacity to conduct both private- and public-sponsored clinical trials. We want to help! If you do, too, please consider supporting the Clinical Research Site Sustainability Fund.
Learn More
The U.S. Food and Drug Administration (FDA) has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method to move new treatments for COVID-19 to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful. […]
Current and prospective clinical trial practitioners sell themselves and the future of the industry short if they view technology as a threat and not an opportunity, says long-time clinical trial leader Kimberly Ray, one of the authors of a new white paper on The Impact of Increased Technology Use on the Clinical Research Workforce. […]
Increasing use of technology and broader adoption of decentralized clinical trials (DCTs) will require an unprecedented transformation of the clinical research workforce. That’s the conclusion of a new white paper published today by the Association of Clinical Research Professionals (ACRP) that highlights the emergence of several new professional roles, as well as anticipated change in […]
Join us learn how to turn your protocol into a fully functional database, translate study objectives into data points that make it easier to manage and analyze your data, and clean and monitor data points throughout the course of the study.
RegisterJoin us for the second part of our presentation on building databases for an Investigator Initiated Trial (IIT)
RegisterJoin Veeva Systems to learn how COVID-19 has resulted in greater need to keep existing clinical trials on track by enabling digital processes and remote access for study monitors.
Register